Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review

Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Vanda Pharmaceuticals Inc (Vanda) is a specialty pharmaceutical company that develops and commercializes novel therapies for the treatment of central nervous system disorders. The company’s products include Hetlioz, a melatonin receptor agonist for the treatment of non-24-hour sleep-wake disorder; and Fanapt, an atypical antipsychotic for the treatment of schizophrenia in adults. Its pipeline portfolio includes Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist for pruritus in atopic dermatitis; VQW-765, an alpha-7 nicotinic acetylcholine receptor for CNS disorders; and VTR-297 for oncology indications. Vanda is headquartered in Washington DC, the US.

Vanda Pharmaceuticals Inc Key Recent Developments

May 01,2019: Vanda Pharmaceuticals reports first quarter 2019 financial results
Apr 24,2019: Vanda Pharmaceuticals names Phaedra Chrousos to Board of Directors
Apr 03,2019: Hagens Berman reminds Vanda Pharmaceuticals investors of April 26, 2019 lead plaintiff deadline and encourages investors to contact the firm
Feb 13,2019: Vanda Pharmaceuticals reports fourth quarter 2018 and full year 2018 financial results
Feb 12,2019: Wolf Popper announces investigation on behalf of investors in Vanda Pharmaceuticals

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Vanda Pharmaceuticals Inc - Key Facts
Vanda Pharmaceuticals Inc - Key Employees
Vanda Pharmaceuticals Inc - Key Employee Biographies
Vanda Pharmaceuticals Inc - Major Products and Services
Vanda Pharmaceuticals Inc - History
Vanda Pharmaceuticals Inc - Company Statement
Vanda Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Vanda Pharmaceuticals Inc - Business Description
Product Category: Fanapt
Overview
Performance
Product Category: HETLIOZ
Overview
Performance
R&D Overview
Vanda Pharmaceuticals Inc - Corporate Strategy
Vanda Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Vanda Pharmaceuticals Inc - Strengths
Vanda Pharmaceuticals Inc - Weaknesses
Vanda Pharmaceuticals Inc - Opportunities
Vanda Pharmaceuticals Inc - Threats
Vanda Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Vanda Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 01, 2019: Vanda Pharmaceuticals reports first quarter 2019 financial results
Apr 24, 2019: Vanda Pharmaceuticals names Phaedra Chrousos to Board of Directors
Apr 03, 2019: Hagens Berman reminds Vanda Pharmaceuticals investors of April 26, 2019 lead plaintiff deadline and encourages investors to contact the firm
Feb 13, 2019: Vanda Pharmaceuticals reports fourth quarter 2018 and full year 2018 financial results
Feb 12, 2019: Wolf Popper announces investigation on behalf of investors in Vanda Pharmaceuticals
Feb 05, 2019: Vanda Pharmaceuticals takes a stand against unnecessary animal research
Nov 07, 2018: Vanda Pharmaceuticals announces third quarter 2018 financial results
Nov 01, 2018: Vanda receives FDA letter regarding corporate webpage
Aug 01, 2018: Vanda pharmaceuticals reports second quarter 2018 financial results
May 02, 2018: Vanda Pharmaceuticals Reports First Quarter 2018 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Vanda Pharmaceuticals Inc, Key Facts
Vanda Pharmaceuticals Inc, Key Employees
Vanda Pharmaceuticals Inc, Key Employee Biographies
Vanda Pharmaceuticals Inc, Major Products and Services
Vanda Pharmaceuticals Inc, History
Vanda Pharmaceuticals Inc, Subsidiaries
Vanda Pharmaceuticals Inc, Key Competitors
Vanda Pharmaceuticals Inc, Ratios based on current share price
Vanda Pharmaceuticals Inc, Annual Ratios
Vanda Pharmaceuticals Inc, Annual Ratios (Cont...1)
Vanda Pharmaceuticals Inc, Interim Ratios
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Vanda Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Vanda Pharmaceuticals Inc, Performance Chart (2014 - 2018)
Vanda Pharmaceuticals Inc, Ratio Charts
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook